Prevalence and Risk Factors of Irritable Bowel Syndrome in Healthy Screenee Undergoing Colonoscopy and Laboratory Tests by Nam, Su Youn et al.
JNM Journal of Neurogastroenterology and Motility 
Original Article
1
J Neurogastroenterol Motil,  Vol. 16  No. 1 January,  2010 
DOI: 10.5056/jnm.2010.16.1.47
ⓒ 2010 The Korean Society of Neurogastroenterology and 
Motility J Neurogastroenterol Motil,  Vol. 16  No. 1 January,  2010
www.jnmjournal.org
Prevalence and Risk Factors of Irritable Bowel 
Syndrome in Healthy Screenee Undergoing 
Colonoscopy and Laboratory Tests
Su Youn Nam, M.D., Ph.D.
1*, Byung Chang Kim, M.D.
1,2, Kum Hei Ryu, M.D.
1, and Bum Joon Park, M.D.
1
1Center for Cancer Prevention & Detection, 
2Center for Colon Cancer, National Cancer Center, Gyeonggi-do, Korea
ㅋ
Introduction
The prevalence of irritable bowel syndrome (IBS) after excluding organic disease has not been reported in Korea.
Methods
Of 5,605 participants in a health screening program, inclusion criteria were persons who underwent colonoscopy and com-
pleted questionnaires. Exclusion criteria were persons diagnosed with colon cancer, inflammatory bowel disease, previous co-
lectomy, and abnormal results of thyroid function tests. IBS was defined by Rome III criteria. Physical and psychological stress 
was evaluated with visual analogue scales, ranging from 0 to 10. Risk factors for IBS were estimated with odds ratios (OR) 
and 95% confidence intervals (CI) using logistic regression analysis.
Results
The prevalence of IBS was 8.2% (5,605) in the total population and 9.1% (393/4,296) in the final study sample. IBS had a 
positive association with female sex (adjusted OR, 1.33; 95% CI, 1.00-1.79; p = 0.05) and current smoking (adjusted OR, 1.31; 
95% CI, 1.00-1.71; p = 0.05). The prevalence of IBS increased with increased psychological stress (adjusted p for trend = 
0.005) and decreased with increasing age (adjusted p for trend ＜0.001), with adjusted OR of 0.95 (95% CI, 0.68-1.33) for 
age of 40.0 to 49.9 years; 0.79 (95% CI, 0.54-1.15) for age of 50.0 to 59.9 years; and 0.51 (95% CI, 0.30-0.86) for age 
of 60 years or more, compared with age less than 40 years. Drinking status, body mass index, hypertension, diabetes, and 
use of sedatives had no association with IBS.
Conclusions
The prevalence of IBS increased with decreasing age and increasing psychological stress, and was positively associated with fe-
male sex and current smoking.
(J Neurogastroenterol Motil 2010;16:47-51)
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Introduction
    Irritable bowel syndrome (IBS) is a chronic, relapsing gas-
trointestinal problem, characterized by abdominal pain, bloating, 
and changes in bowel habits. Although the precise prevalence and 
incidence depends on the criteria used, most studies agree that it 
is a common disorder, and patients present frequently to general 
practitioners and to specialists.
1,2 The prevalence of IBS is ap-
proximately 10% in Western populations
2,3 and 2.6% to 9.6% in 
Korean populations.
4-6 However, previous population-based 
studies did not exclude organic bowel disease using 
colonoscopy.
1,2,4-6 Therefore, we excluded organic bowel disease 
using colonoscopy and abnormal laboratory tests in participants 
in a health screening program, and we evaluated for risk factors of 
IBS after adjusting for many potential confounding factors.
Materials and Methods
1. Study population and questionnaire assessment
    This study is a cross-sectional study using a large self-mo-
tivated health screening cohort at the National Cancer Center, 
Korea. We included participants who underwent a compre-
hensive screening program including colonoscopy and completed 
questionnaires from June 2007 to December 2007. We excluded 
participants who had colorectal cancer, previous colorectal sur-
gery, inflammatory disease of the colon, and abnormal results of 
thyroid function tests.
    The enrolled subjects were racially homogeneous Koreans. 
Personal data (age, sex, alcohol consumption, smoking status, 
personal medical history, gastrointestinal symptoms, job, and so-
cioeconomic status) were collected before endoscopy. Smoking 
and alcohol consumption status was classified as current (daily or 
occasionally) or non-current. Frequent alcohol consumption was 
defined as 4 or more drinks per week. The degree of subjective 
physical and psychological stress was evaluated using a visual an-
alogue scale with responses ranging from 0 (none) to 10 
(extreme); we defined stress as mild for responses of 0 to 2, mod-
erate for 3 to 6, and severe for 7 to 10.
    IBS was diagnosed according to Rome III criteria,
7 which 
have been validated. Recurrent abdominal pain or discomfort at 
least 3 days per month in the last 3 months associated with two or 
more of the following with onset at least 6 months before diag-
nosis: (a) improvement with defecation, (b) onset associated with 
a change in the frequency of stools, and (c) onset associated with a 
change in the form of stools.
        Weight and height measurement was automated 
(X-SCAN PLUS II, Jawon Medical Co., Kyungsan City, 
Korea), and body mass index (BMI) was calculated as weight 
divided by height squared (kg/m
2).
8 Waist circumference was 
measured at the midpoint between the lower borders of the rib 
cage.
2. Colonoscopy
    The day before colonoscopy, participants ingested 45 mL 
aqueous Fleet Phospho-soda (Fleet Company, Inc., Lynchburg, 
VA, USA) in 240 mL water and ingested 10 mg bisacodyl tablets 
followed by 1,500 mL water at 7 pm. They ingested another 45 
mL aqueous Fleet Phospho-soda in 240 mL water followed by 
1,500 mL water at 10 pm. We performed the colonoscopy with a 
colonoscope (Q260AL, Olympus Optical Co., Ltd., Tokyo, 
Japan), recording the location and size of all polypoid and sessile 
lesions. Small polyps, less than 1 cm in diameter, were removed 
by snare polypectomy or hot biopsy during first-look colono-
scopic examination, and large polyps including cancers were 
treated electively by endoscopic mucosal resection or surgical 
operation. All polyps or cancers removed endoscopically or surgi-
cally were fixed in formaldehyde and sent to the pathologic labo-
ratory for routine histologic examination. The histological evalua-
tion was made according to World Health Organization 
(WHO) criteria.
    All of the endoscopic examinations were performed by ex-
perienced endoscopists blinded to the results of the 
questionnaires. Informed consent for sedated endoscopy and use 
of personal data for research purposes was obtained from partic-
ipants before endoscopy.
3. Statistical methods
    Pearson chi-square test or independent t test was employed 
to assess the difference in risk factors between the two groups 
(presence and absence of IBS). Risk factors for IBS were esti-
mated with odds ratios (OR) and 95% confidence intervals (CI) 
using logistic regression analysis. Significant risk factors revealed 
in univariate analysis were subjected to multivariate logistic re-
gression analysis. We used STATA software (version 10, College 
Station, TX, USA) for our analyses. All statistical tests were 
two-sided, and p ＜ 0.05 was considered statistically significant.Su Youn Nam, et al
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Table 1. Baseline Characteristics of Participants in Health Scree-
ning Program
Total 
subjects
(n = 5,605)
Eligible 
subjects
(n = 4,296)
Excluded 
subjects
(n = 1,309)
Male sex 3,140 (56) 2,497 (58) 643 (49)
Age, years 50.6±9.6 50.6±9.7 50.6±9.7
Body mass index, kg/m
2 23.8±2.9 23.8±2.9 23.8±2.8
Current alcohol consumption 3,621 (65) 2,821 (66) 800 (61)
Current smoking 1,506 (28) 1,255 (29) 281 (21)
Hypertension     955 (17)    746 (17) 209 (16)
Diabetes     324 (6)    261 (6)   63 (5)
Depression       61 (1)      44 (1)   17 (1)
IBS by ROME III criteria    461 (8)    393 (9)   68 (5)
IBS, irritable bowel syndrome.
Data are presented as mean±SD or number (percent).
Table 2. Risk Factors for Irritable Bowel Syndrome in the Final 
Study Sample
Absence 
of IBS
a
(n =3 ,903)
Presence 
of IBS
(n = 393)
p-value
Age, years 50.9 ± 9.7 47.7 ± 8.8 ＜0.001
Male sex  2,273 (58)  224 (57)     0.64
Habits or disease
    Current smoking  1,108 (28)  147 (37)     0.001
    Current alcohol consumption  2,541 (66)  280 (71)     0.04
    Frequent alcohol consumption   1,099 (28)  144 (37)     0.009
    Hypertension     699 (18)    47 (12)     0.002
    Diabetes     241 (6)    20 (5)     0.34
    Depression        34 (1)      3 (4)     0.02
Obesity indices 
    Body mass index, kg/m
2 23.8 ± 2.9 23.7 ± 3.0     0.64
    Waist circumference, cm 84.7 ± 8.5 84.2 ± 8.5     0.24
Degree of stress
b
    Physical stress, in the last year   3.7 ± 2.5  4.1 ± 2.4     0.001
    Psychological stress,    4.9 ± 2.5  5.6 ± 2.3     0.001
     in the last year
aIBS denotes irritable bowel syndrome by ROME III criteria, 
bpsychological 
and physical stress was measured by visual analogue scale (0-10).
Data are presented as mean±SD or number (percent).
Table 3. Risk Factors for Irritable Bowel Syndrome by Multiva-
riate Analysis
IBS by ROME III criteria
OR
a (95% CI) p-value
Female sex 1.33 (1.00-1.79) 0.05
Age group 
    40.0 years      1 (Reference)
    40.0-49.9 years 0.95 (0.68-1.33) 0.78
    50.0-59.9 years 0.79 (0.54-1.15) 0.22
    ≥60 years 0.51 (0.30-0.86) 0.01
Current smoking  1.31 (1.00-1.71) 0.05
Current frequent alcohol consumption 1.25  (0.95-1.65) 0.11
Hypertension 1.18  (0.87-1.59) 0.29
Depression 0.31  (0.04-2.28) 0.25
Psychological stress, in the past year
b
    0-2      1 (Reference)
    3-6 1.52 (1.00-2.33) 0.05
    7-10 1.87 (1.18-2.99) 0.008
Physical stress, in the past year
b
    0-2      1 (Reference)
    3-6 1.15 (0.84-1.56) 0.39
    7-10 1.43 (0.92-2.22) 0.11
aadjusted for age, sex, body mass index, smoking status, alcohol consumption 
status, psychological stress status, physical stress status, use of antidepressants, 
and use of sedatives, 
bpsychological and physical stress was measured by visual 
analogue scale; 0-2 is mild, 3-6 is moderate, and 7-10 is severe stress.
CI, confidence interval; IBS, irritable bowel syndrome; OR, odds ratio.
Results
1. Characteristics of participants
    Of 5,605 participants, 4,296 subjects met the study in-
clusion criteria from June 2007 to December 2007. We excluded 
subjects who did not undergo colonoscopy (n = 1,286), those 
with colorectal cancer (n = 16), previous colorectal surgery (n =
1), inflammatory disease of the colon (n = 1), and abnormal re-
sults of thyroid function tests (n = 6). The prevalence of IBS was 
8.2% (461/5,605) in total population and 9.1% (393/4,296) in fi-
nal eligible subjects.
    Distributions of age, body mass index, life style factors, hy-
pertension, diabetes mellitus, and depression were not different 
between total subjects and eligible subjects (Table 1). But preva-
lence of IBS was more common in eligible subjects comparing 
with excluded persons (p = 0.001) (Table 1).
2. Risk factors for irritable bowel syndrome
    IBS had a positive association with current smoking, fre-
quent alcohol consumption, younger age, psychological and 
physical stress, and absence of hypertension, but it had no associ-
ation with sex, BMI, waist circumference, and diabetes mellitus 
(Table 2). Frequent alcohol consumption and current smoking 
had a strong positive association with psychological stress (data 
not shown, both p ＜ 0.001), but not with physical stress.
    In multivariate analysis, psychological stress, female sex, Prevalence of Irritable Bowel Syndrome
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younger age, and current smoking had a positive association with 
IBS (Table 3). If psychological and physical stress were sepa-
rately considered, the prevalence of IBS increased with increasing 
psychological and physical stress (both p for trend ＜ 0.001). If 
they were considered simultaneously, IBS increased with increas-
ing psychological stress (adjusted p for trend = 0.005); adjusted 
OR for IBS was 1.52 (95% CI, 1.00-2.33) for moderate stress 
and 1.87 (95% CI, 1.18-2.99) for severe stress, compared with 
mild stress. However, IBS had no association with physical 
stress. The prevalence of IBS increased with decreasing age 
(adjusted p for trend ＜ 0.001); adjusted OR for IBS was 0.95 
(95% CI, 0.68-1.33) for age of 40.0 to 49.9 years; 0.79 (95% CI, 
0.54-1.15) for age of 50.0 to 59.9 years; and 0.51 (95% CI, 
0.30-0.86) for age of 60 years or more, compared with age less 
than 40 years. Alcohol consumption status and hypertension had 
no association with IBS in multivariate analysis.
Discussion
    We found that the prevalence of IBS was 8.2% in the total 
group of participants and 9.1% in the final study sample, after or-
ganic diseases were excluded. A higher prevalence in the final 
study sample compared with the total population might be ex-
plained by the following. Whereas persons who had lower gastro-
intestinal symptoms such as abdominal discomfort or pain were 
more likely to undergo colonoscopy, persons who had no gastro-
intestinal symptoms were less likely to undergo colonoscopy, and 
thus, they were excluded. In population-based studies, the preva-
lence of IBS by ROME II or III criteria ranged from 2.2% to 
9.6% in Korea.
4-6 In this study, the prevalence of IBS by ROME 
III criteria was similar to that of previous studies.
4,5 The preva-
lence of IBS by ROME II or III criteria is approximately 10% in 
Western populations.
2,3 In other studies, the prevalence of IBS 
was obtained by using validated postal questionnaires or tele-
phone interviews. However, organic diseases should be excluded 
to estimate the prevalence more exactly. We evaluated the preva-
lence of and risk factors for IBS after excluding organic diseases 
in this study.
    IBS was weakly associated with female sex in this study. 
Although previous population-based studies from Korea showed 
a similar prevalence of IBS in both sexes,
4-6 many studies from 
Western populations have shown female predominance.
2,9,10 
Current smoking and frequent alcohol consumption had a strong 
positive association with IBS in univariate analysis; however, in 
multivariate analysis, IBS was weakly associated with current 
smoking and not associated with frequent alcohol consumption. 
In this study, frequent alcohol consumption and current smoking 
had a strong positive association with psychological stress, which 
was strongly associated with IBS, but not with physical stress. 
Therefore, the effect of frequent alcohol consumption on IBS 
might be related to psychological stress, rather than drinking 
itself. Previous studies suggested an association between smoking 
and colonic dysmotility.
11,12 Smokers have a significantly longer 
total colon transit time than nonsmokers,
11 but short-term appli-
cation of nicotine results in decreased total colon transit time, 
which is due to accelerated transit in the rectosigmoid colon.
12
    In this study, when psychological and physical stress was 
separately considered, the prevalence of IBS increased with both 
psychological and physical stress. If they were considered simul-
taneously, however, IBS increased with increasing psychological 
stress, but it had no association with physical stress. People with 
IBS have increased psychological distress
13 compared with peo-
ple who do not have IBS, most commonly depressed, anxious, or 
hypochondriacal.
14-18 Although the results of previous studies 
suggested that this proportion was increased in secondary and 
tertiary care, the results of more recent, large, population-based 
studies suggested that patients with IBS in the community also 
have increased psychological distress
14,19,20 compared with people 
who do not have IBS. A previous study suggested that acute 
stress altered gut-specific efferent autonomic innervations, and 
normalization was delayed in patients with IBS.
21 Actually, ex-
perimentally induced anxiety altered gastric sensorimotor func-
tion,
22 and patients with IBS showed enhanced modulation of vis-
ceral perception by auditory stress.
23
    The prevalence of IBS increased with decreasing age in 
this study, with a decrease of about 50% in participants of age 
more than 60 years, compared with participants of age less than 
40 years. The inverse relationship between IBS and age has been 
suggested in previous studies from Korea, even if they did not 
show a statistical significance for the association between IBS and 
age.
5,6 Previous studies from Western populations have also sug-
gested the association between IBS and young age.
2,9,19
    This study has several strengths. First, we excluded organ-
ic bowel disease by using the results of colonoscopy and abnormal 
laboratory tests. Second, the data were of high quality. Colono-
scopic examinations were performed by gastrointestinal special-
ists, and anthropometric parameters were measured directly in-
stead of by questionnaire. The third strength was the large size of 
the study, which allowed us to evaluate subpopulations and their 
interactions after adjusting for many confounding factors.Su Youn Nam, et al
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    This study also had several limitations. First, the pop-
ulation was a self-motivated screening cohort. The IBS patients 
with severe symptoms may be evaluated as outpatients, so this 
study may underrepresent severely symptomatic IBS patients and 
the prevalence of IBS may be underestimated. However, whereas 
persons who had lower gastrointestinal symptoms were more 
likely to undergo colonoscopy, persons who had no gastro-
intestinal symptoms were less likely to undergo colonoscopy, and 
thus, the prevalence in the eligible subjects was higher than in the 
total population. Finally, the prevalence of IBS in this study is 
similar to the prevalence of IBS in population-based studies using 
telephone interview surveys.
4,5 Because a population based-study 
using colonoscopy may not be realistic, our study using a screen-
ing cohort without serious underlying diseases may be an 
alternative. Second, degrees of psychological and physical stress 
were evaluated by the scores reported by participants subjectively 
using a visual analogue scale, not using validated questionnaires. 
Although there are many methods to assess psychosocial factors, 
there is no standardized method. Therefore, visual analogue 
scales may be alternative tools for assessing psychological and 
physical stress.
    In conclusion, the prevalence of IBS is 9.1% in partic-
ipants in a health screening program after organic diseases were 
excluded, and IBS had a positive association with psychological 
stress, female sex, younger age, and current smoking.
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